Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05304286 · ClinicalTrials.gov registry record · NA

Psychophysical and Neural Mechanisms Contributing to Chronic Post-Surgical Pain in Adolescents and Adults

A NA study of Chronic Post Surgical Pain, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT05304286: Recruiting NA study of Chronic Post Surgical Pain, sponsored by Massachusetts General Hospital.

NCT05304286 is a NA study of Chronic Post Surgical Pain that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 110 participants, below the 357-participant average among 4 other Chronic Post Surgical Pain trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05304286, a NA study of Chronic Post Surgical Pain, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

The current project will (1) enhance our understanding of the neurobiology of chronic post-surgical pain (CPSP); (2) provide a metric to follow patients with CPSP in the clinic; (3) provide a metric for those who will chronify; and (4) understand the age-related differences in CPSP. Ultimately, an improved comprehension of mechanisms linked to CPSP will provide finer tools for optimizing the selection of treatments for individual patients. Moreover, data that demonstrates the underlying pathobiological pain mechanism(s) active in CPSP, particularly those non-responsive to current therapies, may be used to validate novel strategies both pharmacological and non-pharmacological.

Primary Outcome

The 20-item CPAQ-revised has been designed to measure acceptance of pain. The acceptance of chronic pain is thought to reduce unsuccessful attempts to avoid or control pain and thus focus on engaging in valued activities and pursuing meaningful goals. The items on the CPAQ are rated on a 7-point scale from 0 (never true) to 6 (always true). To score the CPAQ, add the items for Activity engagement and Pain willingness to obtain a score for each factor. To obtain the total score, add the scores fo

Conditions Studied

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2022-04-07
Est. Completion 2026-06-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT05304286 shows while recruiting

NCT05304286 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 357-participant average among 4 other Chronic Post Surgical Pain trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Chronic Post Surgical Pain appearing as the primary indexed condition, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.

NCT05304286 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05304286 about?

NCT05304286 is a clinical study titled "Psychophysical and Neural Mechanisms Contributing to Chronic Post-Surgical Pain in Adolescents and Adults". The current project will (1) enhance our understanding of the neurobiology of chronic post-surgical pain (CPSP); (2) provide a metric to follow patients with CPSP in the clinic; (3) provide a metric for those who will chronify; and (4) understand the age-related differences in CPSP. Ultimately, an i...

What is the current status of trial NCT05304286?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2022-04-07. Estimated completion is 2026-06-30.

What conditions does trial NCT05304286 study?

This clinical trial studies the following conditions: Chronic Post Surgical Pain.

What interventions are being tested in trial NCT05304286?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05304286?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05304286 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Post Surgical Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05304286, the US trial registry maintained by the National Library of Medicine. NCT05304286 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.